Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Ruxolitinib
Related studies linked through entity extraction aliases.
Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
- Status
- COMPLETED
- Phase
- PHASE3
A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ruxolitinib Phosphate in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Ruxolitinib in the Treatment of Anemic Myelofibrosis Patients.
- Status
- COMPLETED
- Phase
- PHASE2
An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1)
- Status
- COMPLETED
- Phase
- PHASE2
Ruxolitinib for Premalignant Breast Disease
- Status
- COMPLETED
- Phase
- PHASE2
Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE1
Ruxolitinib Combined With Ibrutinib in Chronic Lymphocytic Leukemia Patients
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Long-Term Side Effects of Ruxolitinib in Treating Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis
- Status
- TERMINATED
- Phase
- PHASE2
Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2